Daisy Yuhas commissions and edits stories for Spectrum on The Transmitter. A freelance science journalist and editor based in Austin, Texas, she has edited features, news and opinions for multiple publications, including SAPIENS and Scientific American MIND. Her writing has appeared in The New York Times, Scientific American, Audubon, The Hechinger Report and Symmetry, among other outlets. (Photograph by Brio Photography)
Daisy Yuhas
Contributing editor
Spectrum
From this contributor
Perspectives from the field: Opinions in autism research
This collection of Spectrum articles from the past 12 months highlights expert perspectives on autism’s heritability and its link to biological sex, the value of transdiagnostic frameworks, and the field’s future, among other topics.
Perspectives from the field: Opinions in autism research
By
Daisy Yuhas
10 July 2025 | 3 min read
Genetic testing; LSD1 inhibitors; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 30 June.
Dosage of X or Y chromosome relates to distinct outcomes; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 23 June.
Dosage of X or Y chromosome relates to distinct outcomes; and more
By
Daisy Yuhas
24 June 2025 | 2 min read
Reporter’s notebook: Highlights from INSAR 2025
The annual meeting brought autism researchers, advocates and clinicians to Seattle to discuss the latest research, including attempts to define subgroups, a potential new CHD8 macaque model and life expectancy gaps.
Spectrum 2024: Year in review
We round up our most notable autism stories of the past 12 months.
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read